Multiple

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-680 After Multiple Oral Doses” in Healthy Volunteers.

Condition:   AsthmaInterventions:   Drug: PBF-680;   Drug: PlaceboSponsors:   Fundació Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau;   Palo Biofarma, S.LRecruiting – verified August 2014 View full post on ClinicalTrials.gov: asthma | received in the last 14 days